MEDICINE DETAILS
Orladeyo
Active ingredient: Berotralstat
Neutral reference profile for an independent medicine-access consultancy enquiry about Orladeyo (Berotralstat). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Orladeyo used for?
Orladeyo (berotralstat) is a plasma kallikrein inhibitor indicated for the prevention of hereditary angioedema (HAE) attacks in adults and children 12 years of age and older.
Because it is not known if Orladeyo (berotralstat) is safe and effective to treat an acute HAE attack, it should not be used to treat an acute HAE attack.
It is available in capsule form containing 150 or 110 mg of berotralstat.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Orladeyo identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
150 mg · 28 capsules Catalogue organisation: BioCryst Ireland Limited
-
150 mg · 98 capsules Catalogue organisation: BioCryst Ireland Limited
OFFICIAL SOURCES
Check the Orladeyo record at an official source.
Search for “Orladeyo” or “Berotralstat”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Orladeyo.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Orladeyo
01What is Orladeyo?＋
This directory record associates the brand name Orladeyo with the active ingredient Berotralstat. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Orladeyo strengths and packs are recorded?＋
The catalogue currently shows: 150 mg · 28 capsules; 150 mg · 98 capsules. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Orladeyo?＋
Catalogue records currently name: BioCryst Ireland Limited. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Orladeyo?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Orladeyo, payment request, stock guarantee or binding offer.
06Can I buy Orladeyo from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.